Division of Hematology and Oncology Archive — Page 14 of 15
-
November 20, 2014
Gene mutation linked to breast cancer therapy resistance
A group of Vanderbilt-led investigators has identified a new gene mutation that may explain why some breast cancer patients do not respond to anti-hormone therapy. -
October 23, 2014
VICC investigators earn breast cancer grants
The grants, which total $830,000, are part of the non-profit organization’s commitment to young scientists, as well as established investigators who are searching for more effective breast cancer therapies. -
September 4, 2014
Lung cancer study reveals new drug combination targets
A Vanderbilt lung cancer patient’s exceptional response to different types of therapies spurred research that suggests lung cancer patients with specific gene alterations may benefit from combination therapy that targets two different cancer pathways. -
July 31, 2014
VICC investigators land Komen breast cancer research grants
Two Vanderbilt-Ingram Cancer Center investigators have received multi-year breast cancer research grants from the Susan G. Komen for the Cure Breast Cancer Foundation. -
July 17, 2014
Lovly’s research bolstered by lung cancer foundation
The LUNGevity Foundation has awarded a 2014 Career Development Award for Translational Research to Christine Lovly, M.D., Ph.D., assistant professor of Medicine and Cancer Biology. -
July 17, 2014
VICC’s Abramson lands breast cancer clinical research award
Vandana Abramson, M.D., assistant professor of Medicine and a breast cancer specialist at Vanderbilt-Ingram Cancer Center, has received the Advanced Clinical Research Award in Breast Cancer from the Conquer Cancer Foundation (CCF). -
February 27, 2014
Probing the pathogenesis of leukemia
A new mouse model reveals gene clusters important in a treatment-resistant form of leukemia.